Literature DB >> 15828745

Intranasal kennel cough vaccine protecting dogs from experimental Bordetella bronchiseptica challenge within 72 hours.

T Gore1, M Headley, R Laris, J G H E Bergman, D Sutton, L J I Horspool, A A C Jacobs.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15828745     DOI： 10.1136/vr.156.15.482

Source DB:  PubMed          Journal:  Vet Rec        ISSN： 0042-4900            Impact factor:   2.695


× No keyword cloud information.
  4 in total

1.  Subcutaneous Immunization of Dogs With Bordetella bronchiseptica Bacterial Ghost Vaccine.

Authors:  Abbas Muhammad; Johannes Kassmannhuber; Mascha Raucher; Alaric A Falcon; David W Wheeler; Alan A Zhang; Petra Lubitz; Werner Lubitz
Journal:  Front Immunol       Date:  2019-06-25       Impact factor: 7.561

Review 2.  The challenges in developing effective canine infectious respiratory disease vaccines.

Authors:  Judy A Mitchell; Joe Brownlie
Journal:  J Pharm Pharmacol       Date:  2015-03-03       Impact factor: 3.765

3.  Bbvac: A Live Vaccine Candidate That Provides Long-Lasting Anamnestic and Th17-Mediated Immunity against the Three Classical Bordetella spp.

Authors:  Monica C Gestal; Laura K Howard; Kalyan K Dewan; Eric T Harvill
Journal:  mSphere       Date:  2022-02-23       Impact factor: 4.389

4.  Comparative onset of immunity of oral and intranasal vaccines against challenge with Bordetella bronchiseptica.

Authors:  Maya M Scott-Garrard; Yu-Wei Chiang; Frederic David
Journal:  Vet Rec Open       Date:  2018-08-13
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.